Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03735290 |
| Title | A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer (ILIAD) |
| Acronym | ILIAD |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Immunicum AB |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Site 1010 | Coral Gables | Florida | 33124 | United States | Details | |
| Site 1006 | Iowa City | Iowa | 52242 | United States | Details | |
| Site 1011 | Louisville | Kentucky | 40202 | United States | Details | |
| Site 1004 | Chapel Hill | North Carolina | 27514 | United States | Details | |
| Site 1009 | Cleveland | Ohio | 44106 | United States | Details |